Skip to main content

Find Clinical Trials

Home
Conditions
Esophageal Diseases

Clinical trial condition

Esophageal Diseases

Explore clinical trials studying Esophageal Diseases. Study availability and eligibility vary by location and protocol.

3,525 public trials 715 recruiting studies

Refine in advanced search Browse all conditions

Esophageal Diseases trial results

Completed

Dysphagia on the Intensive Care Unit

NCT03487510

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +3 more
Locations: Dept. of Intensive Care Medicine, University of Bern, Bern, Switzerland

View Trial Details

Completed

Eccentric Chin Closure Exercise

NCT05240599

Conditions: Deglutition Disorders, Digestive System Diseases, Dysphagia, +4 more
Locations: Hacettepe University Ankara, Turkey (Türkiye)

View Trial Details

Completed

Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC

NCT03985046

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Fudan Universtiy Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)

NCT05444543

Conditions: Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
Locations: University Hospitals Cleveland Medical Center Cleveland, Ohio, United States

View Trial Details

Completed

Acceptability and Tolerance Study of a Thickener

NCT05026476

Conditions: Deglutition Disorders, Digestive System Diseases, Dysphagia, +4 more
Locations: Chelsea and Westminster Hospital Foundation Trust London, United Kingdom

View Trial Details

Completed

Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer

NCT04871204

Conditions: Body Weight, Body Weight Changes, Digestive System Diseases, +15 more
Locations: Karolinska University Hospital, Huddinge Stockholm, Sweden

View Trial Details

Completed

Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)

NCT01393483

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

NCT03430843

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +17 more
Locations: Henry Ford Hospital Detroit, Michigan, United States

Toledo Clinic Cancer Center Toledo, Ohio, United States

Imelda Ziekenhuis Bonheiden Bonheiden, Belgium

Cliniques Universitaires Saint Luc Brussels, Belgium

View all 104 locations

View Trial Details

Completed

BT1718 in Patients with Advanced Solid Tumours.

NCT03486730

Conditions: Advanced Solid Tumours, Bronchial Neoplasms, Carcinoma, Bronchogenic, +18 more
Locations: Queen Elizabeth Hospital Birmingham, United Kingdom

Addenbrookes Hospital Cambridge, United Kingdom

The Beatson Hospital Glasgow, United Kingdom

Royal Marsden Hospital and The Institute of Cancer Research London, United Kingdom

View Trial Details

Completed

BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma

NCT03469557

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +15 more
Locations: Fifth Medical Center of Pla General Hospital Beijing, Beijing Municipality, China

Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China

Northern Jiangsu Peoples Hospital Yangzhou, Jiangsu, China

View Trial Details